ArticleOncology reports2023

Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.

Yuanyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.